Loricrin (LOR) Peptid
LOR
Reaktivität: Säugetier
Wirt: Synthetic
BP, IHC, WB
-
- Target Alle LOR Produkte
- LOR (Loricrin (LOR))
- Protein-Typ
- Synthetic
- Spezies
- Säugetier
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
- Sequenz
- GYSGGGCGGG SSGGGGGGGI GGCGGGSGGS VKYSGGGGSS GGGSGCFSSG
- Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of LOR antibody,
Alternative Names: Loricrin control peptide, Loricrin antibody Blocking Peptide, Anti-Loricrin Blocking Peptide, MGC111513 Blocking Peptide, LOR Blocking Peptide
-
-
- Applikationshinweise
- Optimal conditions should be determined by the investigator
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 °C long term.
-
- Target
- LOR (Loricrin (LOR))
- Substanzklasse
- Chemical
- Hintergrund
- LOR is a major protein component of the cornified cell envelope found in terminally differentiated epidermal cells. Mutations in this gene are associated with Vohwinkel's syndrome and progressive symmetric erythrokeratoderma, both inherited skin diseases.LOR encodes loricrin, a major protein component of the cornified cell envelope found in terminally differentiated epidermal cells. Mutations in LOR may be the cause of both Vohwinkel's syndrome and progressive symmetric erythrokeratoderma, both inherited skin diseases.
- Molekulargewicht
- 35 kDa
-
Sie sind hier:
